Study of two schedules of infliximab maintenance therapy in ankylosing spondylitis: comparison of infusion every 6 weeks versus infusion on demand

Trial Profile

Study of two schedules of infliximab maintenance therapy in ankylosing spondylitis: comparison of infusion every 6 weeks versus infusion on demand

Completed
Phase of Trial: Phase III

Latest Information Update: 15 May 2009

At a glance

  • Drugs Infliximab; Methotrexate
  • Indications Ankylosing spondylitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top